LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced the appointment of Joseph F. McGuire as Chief Financial Officer, effective January 1, 2025. McGuire brings over 30 years of financial and public company leadership to the role, marking an important transition for the company as current CFO, Adam E. Drapczuk III, steps into a consulting position.
Adam Levy, NEXGEL’s CEO, highlighted McGuire’s experience as a key asset for the company. “Joe brings many decades of public company and financial experience that will be invaluable during this critical juncture in our company history,” he said. Levy also expressed gratitude for Drapczuk’s contributions, citing his role in NEXGEL’s recent progress and success. Drapczuk will remain available to the company as a consultant through his firm, Achieving Consulting Excellence, LLC.
McGuire has an extensive background in the healthcare, financial services, and manufacturing sectors, including guiding a biotechnology company to its IPO on the NYSE in 2022. He began his career with Price Waterhouse and held leadership roles at prominent financial firms such as Dean Witter Reynolds and Paine Webber, Inc. McGuire has worked with NEXGEL since September 2024 and will now oversee its finance functions as part of the executive management team.
“It is an exciting time to be part of NEXGEL,” McGuire said. “Adam Levy and his team have executed consistently and exceeded the market’s expectations. I look forward to contributing to the company’s continued growth and success.”
The leadership change marks another step forward for NEXGEL as it focuses on building momentum and navigating its next phase of growth.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.